Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.72 USD
Change Today -0.0044 / -0.61%
Volume 109.2K
BGMD On Other Exchanges
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Noubar B. Afeyan Ph.D.

Founder, Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee,BG Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 173 board members in 18 different organizations across 28 different industries.

See Board Relationships


Dr. Noubar B. Afeyan, Ph.D., is a Co-Founder, Senior Managing Partner and Chief Executive Officer at Flagship Ventures. He was previously a Managing Partner at Flagship Ventures. He also leads the firm's VentureLabs unit that invents and launches transformative startups. He is Co-Founder of Symbiota, Inc. Dr. Afeyan serves as Chairman and Chief Executive Officer of Flagship VentureLabs. He co-founded Pronutria, Inc. in 2012. Dr. Afeyan is a Co-Founded Seres Therapeutics, ...

Read Full Background

Corporate Headquarters*

880 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 781-890-1199
Fax: 781-895-1119

Board Members Memberships*

Co-Founder and Director
Co-Founder and Executive Chairman
Co-Founder, Chairman and Member of Technology Advisory Board
Co-Founder and Chairman of the Board
Member of Board
Director and Chairman of Compensation Committee
Founder, Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee
Co-Founder and Director


PhD 1987
Massachusetts Institute of Technology
McGill University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options12,615
Unexercisable Options4,205
Total Number of Options16,820

Total Compensation*

Total Annual Cash Compensation$21,000
Total Calculated Compensation$23,391
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BGMD:US $0.72 USD -0.0044


David P. King Chairman and Chief Executive Officer
Laboratory Corp. of America Holdings
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
Stephen H. Rusckowski Chief Executive Officer, President, Director and Member of Executive Committee
Quest Diagnostics Inc.
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
Namal Nawana Chief Executive Officer, President and Director
Alere Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BG MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at